You have 9 free searches left this month | for more free features.

Condition

Astrocytoma (1)

Brain Glioblastoma (1)

Glioblastoma (1)

Oligodendroglioma (1)

Recurrent Malignant Glioma (1)

Overall Status

Recruiting (1)

Withdrawn (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Oblato, Inc. (2)

Collaborator

Intervention

okn-007 (2)

temozolomide (tmz) (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

okn-007

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Glioblastoma, Astrocytoma, Oligodendroglioma Trial (OKN-007)

Withdrawn

Glioblastoma
+2 more

OKN-007

(no location specified)

Oct 5, 2022

Recurrent Malignant Glioma, Brain Glioblastoma Trial in United States (OKN-007, Temozolomide (TMZ))

Recruiting

Recurrent Malignant Glioma
Brain Glioblastoma

OKN-007
Temozolomide (TMZ)

Birmingham, Alabama
+12 more

Aug 18, 2022